![]() |
FDA Approves Tzield (teplizumab-mzwv) to Delay Onset of...
December 1, 2022 - Featured , In the News / Politics By: Justin Budz, PharmD Candidate c/o 2023 Diabetes mellitus encompasses both chronic and reversible conditions that affect the body’s ability to utilize glucose. In 2019, about 28.7 million (8.7%) people in the United States (US) had diagnosed diabetes. Of this population, about 1.6 million (5.7%) people ages 20 or older and 244,000 (0.9%) people… |
![]() |
Evaluating the Risk of Neurodevelopmental Disorders fro...
December 1, 2022 - In the News / Politics By: Geraldine Ciaccio, PharmD Candidate c/o 2025 Pregnant women treated with antidepressants may no longer have to endure the worry that their medications will harm their newborn. Previous studies have shown a correlation between the use of antidepressants in pregnant patients and the prevalence of various birth defects, including cardiac defects, anencephaly, and gastroschisis,… |
![]() |
Mounjaro (Tirzepatide): Dual-Targeted Treatment for Typ...
October 1, 2022 - In the News / Politics By: Zarin Chowdhury, PharmD Candidate c/o 2023 and Lauren Merkovich, PharmD Candidate c/o 2023 Type 2 diabetes (T2D) is a long-term medical condition in which the body is unable to use insulin properly, resulting in abnormal blood glucose levels.1 More than 37 million Americans have diabetes (about 1 in 10); approximately 90 to 95%… |
![]() |
New FDA Approval of Bydureon for Treating Type 2 Diabet...
October 1, 2022 - In the News / Politics By: Kelly Lavery, PharmD Candidate c/o 2024 Increasing rates of childhood obesity remain a major risk factor behind a recently increased prevalence of diabetes in the pediatric population. This subject is of particular relevance in light of the ongoing coronavirus disease of 2019 (COVID-19) pandemic, which has limited children to isolation and online learning… |
![]() |
FDA Approves Tubeless Automated Insulin System for Kids...
October 1, 2022 - In the News / Politics By: Geraldine Ciaccio, PharmD Candidate c/o 2025 Young children with type 1 diabetes (T1D) are completely dependent on others for their care and management. It can be hard for parents, guardians, teachers, and healthcare providers to assess a child’s condition as they are too young to properly communicate their thoughts and emotions. Most children… |
![]() |
FDA’s Approval of Pharmacists Prescribing Paxlovid...
October 1, 2022 - In the News / Politics By: Imaan Sekhery, PharmD Candidate c/o 2025 On July 6, 2022, the Food and Drug Administration (FDA) revised the precedent Emergency Use Authorization (EUA) for Pfizer’s Paxlovid, granting licensed pharmacists the right to prescribe Paxlovid to suitable patients. This revision will significantly increase access to Paxlovid, assisting in patient recovery from Coronavirus Disease 2019… |
![]() |
Rectal Cancer Disappears After Use of Immunotherapy...
October 1, 2022 - In the News / Politics By: Sairah Sheikh, PharmD Candidate c/o 2024 Promising new research conducted by doctors at Memorial Sloan Kettering Cancer Center showed 100% remission of rectal cancer in 12 patients after immunotherapy. Traditionally, patients with rectal cancer are treated with chemotherapy and radiation, followed by a surgical resection of the rectum.1 However, this method carries the… |
![]() |
Paxlovid, the First Oral Antiviral Treatment for Covid-...
August 1, 2022 - Featured , In the News / Politics By: Kirby An, PharmD Candidate c/o 2023 Coronavirus Disease (Covid-19) is a virus that took the world by storm with its initial discovery in Wuhan, China in December of 2019. On January 20, 2020, the Centers for Disease Control (CDC) confirmed the first case of Covid-19 in the United States (US) after a 35… |
![]() |
Standing Order for Naloxone in Pharmacies in New York S...
August 1, 2022 - In the News / Politics By: Helen Li, PharmD Candidate c/o 2023 On August 15, 2022, the New York State Commissioner of Health, Dr. Mary T. Bassett, implemented a statewide pharmacy standing order for naloxone.1 With this authorization, all pharmacists can assist in reducing mortality from opioid abuse, while optimizing the pharmacists’ continuous role in public health. In… |
![]() |
Wegovy® (Semaglutide): New FDA Approval for Use in Obe...
August 1, 2022 - In the News / Politics By: Pauline Choi, PharmD There has been an increase in the prevalence of obesity, and it has become an international health problem amongst all age-groups, including children, adults, and adolescents. According to the World Health Organization (WHO), the definition of obesity for adults and children is a BMI > 30 kg/m2, and a weight-for-height… |
![]() |
YouTube Bans Misinformation About Approved Vaccines ...
February 1, 2022 - In the News / Politics By: Natalia Jucha, PharmD Candidate c/o 2022 and Zarin Chowdhury PharmD Candidate c/o 2023 Effective September 29th of 2021, YouTube will be banning prominent anti-vaccine activists and blocking channels promoting anti-vaccine misinformation. The company recently announced its expansion of medical misinformation policies. This includes prohibiting the sharing of misinformation regarding currently administered vaccines that… |
![]() |
CDC Expands Eligibility for COVID-19 Booster Shots ...
February 1, 2022 - Featured , In the News / Politics By: Fatima Amjad, PharmD candidate c/o 2022 Pharmacists have truly taken on the role of superhero during the coronavirus disease 2019 (COVID-19) pandemic. As of April 6, 2022 more than 239.1 million COVID-19 vaccine doses have been administered by community pharmacies across the United States.1 Community pharmacists have gone above and beyond immunizing eligible… |
![]() |
A Review of A Randomized Trial of a Transglutaminase-2 ...
February 1, 2022 - Featured , In the News / Politics By: Natalia Jucha, PharmD Candidate c/o 2022 and Helen Li, PharmD Candidate c/o 2023 Celiac disease is classified as an autoimmune disorder and occurs in individuals who cannot tolerate gluten. Dietary gluten induces an immune response and causes damage to the small intestine, particularly the duodenum and proximal jejunum. A small peptide called gliadin,… |
![]() |
Good News, Bad News about Novel Treatment Resistant Dep...
December 1, 2021 - Featured , In the News / Politics By: Daniel Levin, PharmD candidate c/o 2022 Depression is a terrible beast of an illness to battle with, and there are nearly 14 million individuals at any given moment fighting it. Only around 50% of patients struggling with depression will get some form of treatment. Sixty to seventy percent of patients who do get… |
![]() |
An Aspirin A Day Keeps the First Heart Attack Away… N...
December 1, 2021 - Featured , In the News / Politics By: Jun Suh Hong, PharmD candidate c/o 2022 Aspirin belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDS). Known by many for its analgesic and anti-inflammatory properties, as well as its association with gastrointestinal (GI) bleeding, aspirin plays an essential role in stroke prevention. As such, it has a crucial role in… |
![]() |
Cabenuva: A Monthly Injectable for the Treatment of HIV...
December 1, 2021 - Featured , In the News / Politics By: Sharon Joseph PharmD Candidate c/o 2022 and Salma Hewady, PharmD Human immunodeficiency virus (HIV) is a single-stranded retrovirus that attacks the immune system, predisposing the host to opportunistic infections and malignancies. If not properly treated, HIV can progress to Acquired Immunodeficiency Syndrome (AIDS). Goals of therapy include restoration of immune function, suppression of… |
![]() |
Opioid Addiction During a Public Health Crisis...
October 1, 2021 - Featured , In the News / Politics By: Anjali Rana, PharmD Candidate c/o 2025 and Katharine Russo, PharmD The Coronavirus disease 2019 (COVID-19) pandemic continues to pose challenges, both nationally and worldwide. Many countries that were facing public health crises prior to COVID-19 have subsequently seen a worsening of these crises, as much of the funding and attention previously available has… |
![]() |
Ranitidine (Zantac®) Making a Comeback...
October 1, 2021 - Featured , In the News / Politics By: Mandy Zheng, PharmD Candidate c/o 2024 “Where can I find Zantac?”. From April 2020 to May 2021, the answer was, you cannot. On April 1, 2020, the Food and Drug Administration (FDA) ordered for all ranitidine (Zantac®)- containing products to be removed from the U.S. market.¹ Ranitidine was a popular over-the-counter (OTC) and… |
![]() |
Pharmacy Meets Technology: Pharmacy Informatics...
October 1, 2021 - In the News / Politics , Professional Advice / Opinions By: Tiffany Dominic, PharmD Candidate c/o 2022 As student pharmacists, there is no doubt that we have been hearing the words “pharmacy informatics” more frequently. However, a big concern remains. Many pharmacy students are not exactly sure what informatics is or only have a general understanding of the topic. Well, look no further and… |
![]() |
Drug Information Questions: Vaccines are Drugs Too...
August 1, 2021 - In the News / Politics By: Aisa Mrkulic, Maria Michael and Svetlana Bachayev, PharmD Candidates c/o 2022 With the surge of Coronavirus Disease 2019 (COVID-19) vaccines sweeping the nation, there have been many concerns surrounding their safety and impact on everyday life as we adjust to the new normal. During our Introductory Pharmacy Practice Experience (IPPE) at Long Island… |
![]() |
CAR T-cell therapy for Multiple Myeloma...
August 1, 2021 - Featured , In the News / Politics By: Lyana Sayilar, PharmD Candidate c/o 2022 Multiple myeloma is characterized by an accumulation of abnormal plasma cells in the bone marrow and the formation of tumors in bones. An insufficient quantity of healthy blood cells are produced in the bone marrow leading to a weakened immune system.1 The exact cause of multiple myeloma… |
![]() |
A New Approach with an Old Drug: Colchicine and Heart D...
August 1, 2021 - In the News / Politics By: Mathew Fontanez, PharmD Candidate c/o 2022 What place does the familiar gout medication colchicine have in the fight against heart disease? Colchicine and its natural source, the autumn crocus plant, have been used to treat the “disease of kings”, or gout, for well over 2000 years. As a result of hyperuricemia, gout often… |
![]() |
Potentially Life-Threatening Interactions Between Newer...
August 1, 2021 - Featured , In the News / Politics By: Richa Tamakuwala, PharmD Candidate c/o 2022 There has been a dramatic rise in the number of patients with cardiovascular implantable electronic devices (CIEDs), such as permanent pacemakers and implantable cardioverter‐defibrillators (ICDs), due to an increasing aging population and clinical trials showing benefits in mortality and morbidity. Multiple studies investigating the use of ICDs… |
![]() |
Pharmaceutical Breakthrough for the Treatment of Duchen...
June 1, 2021 - Featured , In the News / Politics By: Rubab Hassan, PharmD Candidate c/o 2022 Duchenne muscular dystrophy (DMD) is a genetic disorder that causes muscle degeneration and weakness along with various other symptoms. It is predominantly caused by deletions of one or more exons, which lead to mutations of the dystrophin gene. Dystrophin stops muscle fibers from being degraded by proteases.… |
![]() |
Desmopressin Challenge for Von Willebrand’s Disease i...
June 1, 2021 - Featured , In the News / Politics By: Oluwafemi Popoola, PharmD Candidate c/o 2021, SUNY Binghamton School of Pharmacy & Pharmaceutical Sciences A patient with past medical history of von Willebrand’s disease (VWD) and myasthenia gravis on chronic prednisone therapy, presented for follow-up for VWD at the hematology/oncology clinic. The provider considered having the patient undergo a “desmopressin challenge” with desmopressin… |
![]() |
Correlation of Salt-Intake and Hypertension...
June 1, 2021 - Featured , In the News / Politics By: Jordan Plair, PharmD Candidate c/o 2022 and Marina Beshara, PharmD Candidate c/o 2022 While the focus over the last year has been fixated on the deadly coronavirus, the importance of a long-standing health pandemic exacerbated by salt intake cannot be overlooked. Hypertension, more commonly referred to as high blood pressure, is a medical… |
![]() |
FDA approves Vibegron (Gemtesa®) for the Treatment of ...
June 1, 2021 - Featured , In the News / Politics By: Arya Firoozan, PharmD Candidate c/o 2023 Overactive bladder (OAB) is a condition that causes a sudden and frequent urge to urinate. It is also associated with incontinence and nocturia. Nocturia refers to waking up at night due to the urge to urinate. OAB is diagnosed if there is no other current infection or… |
![]() |
Connecting the Dots: Ankylosing Spondylitis and Heart D...
June 1, 2021 - Featured , In the News / Politics By: Jennifer Galvet, PharmD Candidate c/o 2024 Ankylosing spondylitis (AS) is a systemic inflammatory condition that primarily affects a person’s back.¹ It is a form of arthritis that affects the spine and causes inflammation of the spinal joints, leading to severe, chronic pain and discomfort.² Ankylosing spondylitis can also impact other areas of the… |
![]() |
Bamlanivimab for the treatment of COVID-19...
April 1, 2021 - Featured , In the News / Politics By: Daniela Farzadfar, PharmD,PGY-1 Resident at Long Island Jewish Medical Center In March 2020, the World Health Organization (WHO) declared coronavirus disease- 2019 (COVID-19) a global pandemic. 1 To date, over 30 million cases of COVID-19 have been reported in the United States and drug companies have been scrambling to develop therapies for the… |
![]() |
Insulin Monitoring System for Pediatric patients...
April 1, 2021 - Featured , In the News / Politics By: Lyana Sayilar, PharmD Candidate c/o 2022 On August 31, 2020, the FDA approved the first automated diabetes management device for patients aged 2 to 6-years old. The MiniMed 770G System automatically adjusts basal insulin doses based on glucose levels, facilitating the lives of the patient and caregiver. Prior to its approval, patients and/or… |
![]() |
Who is COVID-19 hitting the hardest?...
April 1, 2021 - Featured , In the News / Politics By: Pooja Dasgupta and Sonya Wadhawan, PharmD Candidates c/o 2025 The coronavirus, also known as SARS CoV-2 or COVID-19, has widely affected various people globally. The study of SARS CoV-2 has shifted from studying individuals and their unique symptoms during their disease duration to studying different populations and their backgrounds that increase the risk… |
![]() |
Fostemsavir: New drug for the treatment of HIV-1 resist...
April 1, 2021 - Featured , In the News / Politics By: Bisma Sekhery, PharmD Candidate c/o 2021 Fostemsavir (Rukobia) is a new Food and Drug Administration (FDA) approved antiretroviral agent for the treatment of Human Immunodeficiency Virus (HIV). It was approved in July 2020 for multidrug-resistant HIV-1. It is a pro-drug, metabolized to its active moiety, temsavir, which binds to the gp120 subunit within… |
![]() |
AstraZeneca Sells Rights to Two Cardiovascular Drugs fo...
April 1, 2021 - Featured , In the News / Politics By: Jennifer Galvet, PharmD Candidate c/o 2024 Introduction The British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca has agreed to sell its rights to two cardiovascular drugs to Germany’s Cheplapharm Arzneimittel GmbH for $400 million. This decision allows AstraZeneca to reinvest in the company’s main areas of focus: cardiovascular, renal and metabolism, cancer, respiratory, inflammation and… |
![]() |
Daniel Schneider RPh.’s crusade against OxyContin...
February 1, 2021 - Featured , In the News / Politics By: Alisha Kuriakose, PharmD Candidate c/o 2022 “The Pharmacist” is a Netflix documentary that showcases pharmacist Dr. Daniel Schneider’s crusade against OxyContin® abuse. It highlights his discovery of a corrupt doctor who exploited her medical license and destroyed communities in Louisiana. It also illustrates his fight to expose Purdue Pharma of falsely reporting the addictive… |
![]() |
EndeavourRx ™: The Prescription-Only, FDA-Approved Vi...
February 1, 2021 - Featured , In the News / Politics By: Aiśa Mrkulic PharmD Candidate c/o 2022 Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common reasons children require referrals for mental health services.¹ In fact, the American Academy of Pediatrics (AAP) recommends the screening of every child with ADHD for neuropsychiatric comorbidities. With, “one in every 20 children affected,” it exists… |
![]() |
FDA Approves GlaxoSmithKline’s Combined Formulation o...
February 1, 2021 - Featured , In the News / Politics By: Edwin Gruda, PharmD Candidate c/o 2022; Aiśa Mrkulic, PharmD. Candidate c/o 2022 Over-the-Counter (OTC) medications are typically used for mild pain relief. Many patients rely on their OTC medications to treat headaches, fevers, muscle pain, tooth aches and mild arthritis. In March of 2020, the Food and Drug Administration (FDA) approved a new… |
![]() |
NMOSD Treatment...
February 1, 2021 - Featured , In the News / Politics By: Lyana Sayilar PharmD. Candidate c/o 2022 Neuromyelitis optica spectrum disorder (NMOSD) is a rare disorder affecting 4,000 to 8,000 Americans. Adults with this disorder are often found to have anti-aquaporin-4 (AQP4)antibodies that primarily attack healthy cells and proteins in the optic nerves and spinal cord. The majority of patients have relapses within three… |
![]() |
Flu Shot Season, COVID-19 and How Pharmacies are Bracin...
February 1, 2021 - Featured , In the News / Politics By: Rebecca Samuel, PharmD Candidate c/o 2022 and Pallak Sharma, PharmD Candidate c/o 2022 It is flu shot season! That’s a phrase that causes almost every pharmacy staff member to take a deep breath. Amid the pandemic, flu shot season is busier than ever and it is directly affecting pharmacies across the country. In… |
![]() |
MIS-C: The Impact of COVID-19 on the Pediatric Populati...
December 1, 2020 - Featured , In the News / Politics By: Erica Tonti, PharmD Candidate c/o 2022 Multisystem Inflammatory Syndrome in Children, or MIS-C, is a recent syndrome recognized by the Centers for Disease Control and Prevention (CDC). The emergent outbreak of COVID-19 brought concern as to who would be affected by MIS-C and how severe the impact of the syndrome would be. Children, thought to… |
![]() |
Next Up in the World of Hyperlipidemia: Nexletlol TM...
December 1, 2020 - Featured , In the News / Politics By: Preethi Samuel, Pharm.D. Candidate c/o of 2021 In the United States, at least one person has a heart attack every 40 seconds and 1 of every 5 is silent.1 Heart attacks are commonly a result of atherosclerotic cardiovascular disease (ASCVD). Preceding plaque buildup in arterial walls can potentially lead to a heart attack… |
![]() |
A New Drug Class for Heart Failure—Dapagliflozin’s ...
December 1, 2020 - Featured , In the News / Politics By: Adrian Wong, PharmD Candidate c/o 2021 On May 5, 2020, the Food and Drug Administration (FDA) announced its approval for Farxiga® (dapagliflozin) oral tablets to have a new indication: to lower the risk of cardiovascular death and hospitalization for adults with New York Heart Association (NYHA) functional class II-IV heart failure (HF) with reduced… |
![]() |
Provider Status: What is it?...
October 1, 2020 - Featured , In the News / Politics By: Katharine Russo, PharmD Candidate c/o 2021 As of July 1, 2000, the Accreditation Council for Pharmacy Education (ACPE) mandated for the Doctor of Pharmacy (PharmD) degree to be the sole degree required to enter pharmacy practice in the United States. ¹ With this advanced degree came the complex education, training, and clinical practice… |
![]() |
The Psychological impact of COVID-19 on Mental Health &...
October 1, 2020 - Featured , In the News / Politics By: Shea Dorsey, PharmD Candidate c/o 2021 COVID-19 has taken a major toll on the mental wellbeing of people around the world and continues to do so today, almost 7 months after the United States first announced quarantine. Many individuals previously diagnosed with an anxiety disorder, depressive disorder, trauma-and stressor-related disorder (TSRD) or expressed… |
![]() |
New York State and Provider Status...
October 1, 2020 - Featured , In the News / Politics By: Mah Noor, PharmD Candidate c/o 2021 Over the past decade, pharmacists across the nation have joined in a number of grassroots efforts to gain legislative recognition as health care providers. As of 2019, thirty-four states have recognized pharmacists as providers in at least one section of their state statute or in their state… |
![]() |
The State of Pharmacy Advocacy in New York...
October 1, 2020 - Featured , In the News / Politics By: Jeremy Mesias, PharmD Candidate c/o 2022 As we begin another October, we mark the start of American Pharmacist Month and celebrate pharmacists and their work around the country. We are also reminded of the great leaps and bounds our profession has made over the years to advance patient care. Behind all great progress,… |
![]() |
Metastatic Breast CancER+ Treatment...
August 1, 2020 - Featured , In the News / Politics By: Lyana Sayilar, PharmD Candidate c/o 2020 Approved on April 17, 2020, tucatinib (TukysaTM) is indicated to aid in the treatment of human epidermal growth factor receptor 2 (HER2) positive metastatic breast cancer and could be a potential add-on therapy.3 Among the different types of breast cancers, an increase of HER2, a transmembrane glycoprotein consisting… |
![]() |
COVID-19 and the vaccine development process: A closer ...
August 1, 2020 - Featured , In the News / Politics By: Jason Ifeanyi, PharmD Candidate c/o 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain responsible for causing COVID-19, continues to have a profound impact on communities at a local, national and global level. As of August 20, 2020, nearly 5.7 million confirmed cases exist in the United States with a total of… |
![]() |
When Epidemic Meets Pandemic: Treatment of Opioid Use D...
June 1, 2020 - Featured , In the News / Politics By: Preethi Samuel, PharmD Candidate c/o 2021, Aisa Mrkulic, PharmD. Candidate c/o 2022 Opioid use disorder (OUD) is a chronic illness involving misuse of opioids, both prescribed and non-prescribed, as well as the use of illicitly obtained heroin. OUD carries a risk of fatal overdose, preceded by the following triad: pinpoint pupils, respiratory depression,… |
![]() |
Dexamethasone and COVID-19...
June 1, 2020 - Featured , In the News / Politics By: Natalia Loomis, PharmD Candidate c/o 2022 The World Health Organization announced the official name “COVID-19” on February 11, 2020 when the outbreak was first identified in Wuhan, China. ‘CO’ stands for ‘corona,’ ‘VI’ for ‘virus,’ and ‘D’ for disease and 19 for the year the first case occurred.2 The Center for Disease Control and… |
![]() |
NIH COVID-19 Treatment Guidelines Update: remdesivir, c...
June 1, 2020 - Featured , In the News / Politics By: Jason Ifeanyi, PharmD Candidate c/o 2022 Severe acute respiratory syndrome 2 (Sars-Cov-2), the viral strain responsible for causing COVID-19, continues to have an undeniable impact both on a national level and a global level. As of June 20th, 2020, there have been nearly 2.4 million reported cases in the United States, with nearly 122,000… |